×
Brainsway Total Assets 2018-2024 | BWAY
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Brainsway total assets from 2018 to 2024. Total assets can be defined as the sum of all assets on a company's balance sheet.
View More
Brainsway Total Assets 2018-2024 | BWAY
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Brainsway total assets from 2018 to 2024. Total assets can be defined as the sum of all assets on a company's balance sheet.
Related Stocks
Company Name
Market
Cap
Abbott Laboratories (ABT)
$205.5B
Stryker (SYK)
$138.7B
Boston Scientific (BSX)
$121.5B
Medtronic (MDT)
$113.7B
EssilorLuxottica (ESLOY)
$104.2B
Haleon (HLN)
$48.6B
Lonza Group Ag (LZAGY)
$45.9B
ResMed (RMD)
$36.9B
Koninklijke Philips (PHG)
$29.3B
Terumo (TRUMY)
$27.8B
Zimmer Biomet Holdings (ZBH)
$21.6B
Baxter (BAX)
$20.3B
Insulet (PODD)
$16.5B
Smith & Nephew SNATS (SNN)
$13.5B
Bio-Rad Laboratories (BIO)
$9.3B
Demant (WILYY)
$9.2B
BellRing Brands (BRBR)
$7.7B
Lantheus Holdings (LNTH)
$7.3B
ICU Medical (ICUI)
$4.3B
Haemonetics (HAE)
$3.9B
TG Therapeutics (TGTX)
$3.9B
GN Store Nord (GNNDY)
$3.8B
Perrigo (PRGO)
$3.8B
Neogen (NEOG)
$3.7B
Prestige Consumer Healthcare (PBH)
$3.6B
Envista Holdings (NVST)
$3.3B
QuidelOrtho (QDEL)
$3.1B
Agios Pharmaceuticals (AGIO)
$2.6B
Maravai LifeSciences Holdings (MRVI)
$2.3B
Green Thumb Industries (GTBIF)
$2.2B